Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCDC88B encodes a cytoskeletal scaffold protein with a coiled-coil and hook-related domain architecture. It is primarily expressed in hematopoietic organs and immune cells, including T lymphocytes and myeloid lineages, but not B lymphocytes. It regulates T cell maturation, activation, and cytokine production, and controls NK cell cytotoxicity as well as dendritic cell migration through cytoskeleton interactions. CCDC88B interacts physically and functionally with other signaling molecules—including ARHGEF2, RASAL3, HSPA5, and DOCK8—that modulate immune responses, vesicular trafficking, and apoptosis. The gene is situated at chromosome locus 11q13, associated with risk for several inflammatory and autoimmune disorders. Its precise biochemical mechanisms are largely linked to its role as a cytoskeletal scaffold, coupling organelle transport and immune cell activation. Despite its strong linkage to disease susceptibility, it is not currently targeted by approved drugs and presents a complex safety profile due to its essential functions in immune regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 88B (CCDC88B).